“The Vitamin B12 Receptor CD320 Is a Key Metabolic Dependency and Prognostic Biomarker in Hepatocellular Carcinoma”, HSET, vol. 162, pp. 227–240, Apr. 2026, doi: 10.54097/wzcyfb37.